Clinical Trials Browser

Interventional × Urinary Bladder Neoplasms × temsirolimus × Clear all

NCT01827943 2021-05-06

VESTOR

Phase 2 Completed

54 enrolled 8 charts

Urinary Bladder Neoplasms

NCT01090466 2018-02-06

Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium

Phase 1/2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms